Table 1.
Characteristics of the studies investigating the admission rate for acute myocardial infarction during the COVID-19 pandemic.
| First author [Ref#] | AMI type | Country | COVID-19 period considered | Patients (n) | Control period considered | Patients (n) | Percent change in AMI admissions |
|---|---|---|---|---|---|---|---|
| Xiang et al. (24) | STEMI | China | 27 Dec 2019–23 Jan 2020 | 15,729 | 24 Jan−20 Feb 2020 | 11,598 | −26% |
| De Rosa et al. (25) | STEMI/NSTEMI | Italy | 12 Mar−19 Mar 2020 | 319 | 12 Mar−19 Mar 2019 | 618 | −48% |
| Rodriguez-Leor et al. (26) | STEMI | Spain | 16 Mar−22 Mar 2020 | 260 | 24 Jan−1 Mar 2020 | 433 | −40% |
| Garcia et al. (27) | STEMI | United States | 1 Mar−31 Mar 2020 | 138 | 1 Jan 2019–29 Feb 2020 | >180/month | −38% |
| Mafham et al. (28) | STEMI/NSTEMI | England | 1 Jan−24 May 2020 | 1,813/week | 1 Jan−31 Dec 2019 | 3,017/week | −40% |
| Mesnier et al. (29) | STEMI/NSTEMI | France | 16 Mar−12 Apr 2020 | 481 | 17 Feb−15 Mar 2020 | 686 | −30% |
| Papafaklis et al. (30) | ACS | Greece | 2 Mar−12 Apr 2020 | 771 | 2 Mar−12 Apr 2019 | 1,077 | −38% |
| Solomon et al. (31) | STEMI/NSTEMI | United States | 4 Mar−14 Apr 2020 | 516 | 4 Mar−14 Apr 2019 | 735 | −30% |
| Mohammad et al. (32) | STEMI/NSTEMI | Sweden | 1 Mar−7 May 2020 | 36/day | 1 Mar−7 May 2015-2019 | 45/day | −20% |
| Gluckman et al. (33) | STEMI/NSTEMI | United States | 23 Feb−28 Mar 2020 | 860 | 30 Dec 2018–22 Feb 2020 | - | −19% |
| Wilson et al. (34) | STEMI | United Kingdom | 19 Feb−8 Apr 2020 | 388 | 19 Feb−8 Apr 2017-2019 | - | −51% |
ACS, acute coronary syndrome; NSTEMI, non-ST elevation myocardial infarction; STEMI, ST-elevation myocardial infarction.